ReShape Lifesciences Statistics
Total Valuation
RSLS has a market cap or net worth of $4.12 million. The enterprise value is $4.39 million.
Important Dates
The last earnings date was Friday, April 4, 2025, after market close.
| Earnings Date | Apr 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RSLS has 11.28 million shares outstanding. The number of shares has increased by 401.98% in one year.
| Current Share Class | 11.28M |
| Shares Outstanding | 11.28M |
| Shares Change (YoY) | +401.98% |
| Shares Change (QoQ) | +40.20% |
| Owned by Insiders (%) | 0.34% |
| Owned by Institutions (%) | 8.59% |
| Float | 11.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.02 |
| Forward PS | n/a |
| PB Ratio | -16.27 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.92
| Current Ratio | 0.92 |
| Quick Ratio | 0.34 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -222.46% and return on invested capital (ROIC) is -109.11%.
| Return on Equity (ROE) | -222.46% |
| Return on Assets (ROA) | -53.93% |
| Return on Invested Capital (ROIC) | -109.11% |
| Return on Capital Employed (ROCE) | 3,472.92% |
| Revenue Per Employee | $444,778 |
| Profits Per Employee | -$396,111 |
| Employee Count | 18 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 0.95 |
Taxes
In the past 12 months, RSLS has paid $39,000 in taxes.
| Income Tax | 39,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.26% in the last 52 weeks. The beta is 1.92, so RSLS's price volatility has been higher than the market average.
| Beta (5Y) | 1.92 |
| 52-Week Price Change | -96.26% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 5.34 |
| Relative Strength Index (RSI) | 42.03 |
| Average Volume (20 Days) | 44,303,479 |
Short Selling Information
The latest short interest is 688,716, so 6.11% of the outstanding shares have been sold short.
| Short Interest | 688,716 |
| Short Previous Month | 367,182 |
| Short % of Shares Out | 6.11% |
| Short % of Float | 6.13% |
| Short Ratio (days to cover) | 1.14 |
Income Statement
In the last 12 months, RSLS had revenue of $8.01 million and -$7.13 million in losses. Loss per share was -$13.83.
| Revenue | 8.01M |
| Gross Profit | 5.06M |
| Operating Income | -6.67M |
| Pretax Income | -10.87M |
| Net Income | -7.13M |
| EBITDA | -6.65M |
| EBIT | -6.67M |
| Loss Per Share | -$13.83 |
Full Income StatementBalance Sheet
The company has $693,000 in cash and $967,000 in debt, giving a net cash position of -$274,000 or -$0.02 per share.
| Cash & Cash Equivalents | 693,000 |
| Total Debt | 967,000 |
| Net Cash | -274,000 |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | -253,000 |
| Book Value Per Share | -0.35 |
| Working Capital | -397,000 |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.43M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.43M |
| FCF Per Share | -$0.39 |
Full Cash Flow StatementMargins
Gross margin is 63.17%, with operating and profit margins of -83.29% and -89.06%.
| Gross Margin | 63.17% |
| Operating Margin | -83.29% |
| Pretax Margin | -88.57% |
| Profit Margin | -89.06% |
| EBITDA Margin | -83.01% |
| EBIT Margin | -83.29% |
| FCF Margin | n/a |